New awareness BCYWF articles explain how age, tumor subtype, fertility, and endocrine therapy influence diagnosis, ...

A new study led by UC San Francisco has found an alarming rise in invasive breast cancer among Asian American women over the ...

A multi-institutional team of scientists has developed a free, publicly accessible resource to aid in classification of patient tumor samples based on distinct molecular features identified by The ...

Adding targeted therapy Kisqali (ribociclib) to the standard treatment plan can significantly reduce the risk of cancer coming back for patients with hormone receptor-positive (HR+) breast cancer.

Breast cancer is the most common malignancy in women, posing a serious threat to female health. Due to the high inter- and intra-tumoral heterogeneity of breast cancer, clinical treatment and ...

Breast cancer is the second leading cause of cancer deaths in the U.S. and worldwide, pointing to the continuing need to improve treatment strategies and therapies that better patient survival and ...

According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle ...

Researchers have developed a blood test that can reliably detect neuroendocrine prostate cancer and differentiate it from castration-resistant prostate cancer-adenocarcinoma (CRPC-adeno). Like a ...

Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...